{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:05:05Z","timestamp":1778177105256,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11010-025-05271-6","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T05:48:59Z","timestamp":1743486539000},"page":"4573-4586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gut microbiota and microRNAs as biomarkers in Parkinson\u2019s disease: early identification, diagnostic and potential treatments"],"prefix":"10.1007","volume":"480","author":[{"given":"Javier","family":"Hern\u00e1ndez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Muro-Reche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3979-6678","authenticated-orcid":false,"given":"Esteban","family":"Orenes-Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"issue":"1","key":"5271_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","volume":"10","author":"D Kwon","year":"2024","unstructured":"Kwon D, Zhang K, Paul KC, Folle AD, Del Rosario I, Jacobs JP, Keener AM, Bronstein JM, Ritz B (2024) Diet and the gut microbiome in patients with Parkinson\u2019s disease. NPJ Parkinsons Dis 10(1):89. https:\/\/doi.org\/10.1038\/s41531-024-00681-7","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"5271_CR2","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.1038\/s41598-024-59250-w","volume":"14","author":"ZSW Chui","year":"2024","unstructured":"Chui ZSW, Chan LML, Zhang EWH, Liang S, Choi EPH, Lok KYW, Tun HM, Kwok JYY (2024) Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis. Sci Rep 14(1):9558. https:\/\/doi.org\/10.1038\/s41598-024-59250-w","journal-title":"Sci Rep"},{"key":"5271_CR3","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1080\/10408398.2018.1484340","volume":"59","author":"A Larroya-Garc\u00eda","year":"2019","unstructured":"Larroya-Garc\u00eda A, Navas-Carrillo D, Orenes-Pi\u00f1ero E (2019) Impact of gut microbiota on neurological diseases: diet composition and novel treatments. Crit Rev Food Sci Nutr 59:3102\u20133116. https:\/\/doi.org\/10.1080\/10408398.2018.1484340","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"9","key":"5271_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/cells13090770","volume":"13","author":"C Vilela","year":"2024","unstructured":"Vilela C, Ara\u00fajo B, Soares-Guedes C, Caridade-Silva R, Martins-Macedo J, Teixeira C, Gomes ED, Prud\u00eancio C, Vieira M, Teixeira FG (2024) From the gut to the brain: is microbiota a new paradigm in Parkinson\u2019s disease treatment? Cells 13(9):770. https:\/\/doi.org\/10.3390\/cells13090770","journal-title":"Cells"},{"issue":"599\u2013609","key":"5271_CR5","doi-asserted-by":"publisher","first-page":"609.e1","DOI":"10.1053\/j.gastro.2011.04.052","volume":"141","author":"P Bercik","year":"2011","unstructured":"Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF, Collins SM (2011) The intestinal microbiota affects central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141(599\u2013609):609.e1\u20133. https:\/\/doi.org\/10.1053\/j.gastro.2011.04.052","journal-title":"Gastroenterology"},{"issue":"3","key":"5271_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11427-014-4615-4","volume":"57","author":"J Luo","year":"2014","unstructured":"Luo J, Wang T, Liang S, Hu X, Li W, Jin F (2014) Ingestion of lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Life Sci 57(3):327\u2013335. https:\/\/doi.org\/10.1007\/s11427-014-4615-4","journal-title":"Sci China Life Sci"},{"key":"5271_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-319-20215-0_5","volume":"874","author":"BT Green","year":"2016","unstructured":"Green BT, Brown DR (2016) Interactions between bacteria and the gut mucosa: do enteric neurotransmitters acting on the mucosal epithelium influence intestinal colonization or infection? Adv Exp Med Biol 874:121\u2013141. https:\/\/doi.org\/10.1007\/978-3-319-20215-0_5","journal-title":"Adv Exp Med Biol"},{"key":"5271_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106948","volume":"123","author":"I Rajkovaca Latic","year":"2024","unstructured":"Rajkovaca Latic I, Popovic Z, Mijatovic K, Sahinovic I, Pekic V, Vucic D, Cosic V, Miskic B, Tomic S (2024) Association of intestinal inflammation and permeability markers with clinical manifestations of Parkinson\u2019s disease. Parkinsonism Relat Disord 123:106948. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106948","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"5271_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/10408363.2020.1833298","volume":"58","author":"D Navas-Carrillo","year":"2021","unstructured":"Navas-Carrillo D, Rivera-Caravaca JM, Sampedro-Andrada A, Orenes-Pi\u00f1ero E (2021) Novel biomarkers in Alzheimer\u2019s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites. Crit Rev Clin Lab Sci 58(3):167\u2013179. https:\/\/doi.org\/10.1080\/10408363.2020.1833298","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"5271_CR10","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.ijcard.2012.09.120","volume":"167","author":"E Orenes-Pi\u00f1ero","year":"2013","unstructured":"Orenes-Pi\u00f1ero E, Montoro-Garc\u00eda S, Patel JV, Vald\u00e9s M, Mar\u00edn F, Lip GYH (2013) Role of microRNAs in cardiac remodelling: new insights and future perspectives. Int J Cardiol 167(5):1651\u20131659. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.120","journal-title":"Int J Cardiol"},{"key":"5271_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2024.100098","volume":"3","author":"M Sahoo","year":"2024","unstructured":"Sahoo M, Behera JK, Behera B, Jena B, Behera BL, Bhattacharya M (2024) Interplay between gut microbiota and the role of microRNA mechanisms, pathways in cardiovascular diseases. Microbe 3:100098. https:\/\/doi.org\/10.1016\/j.microb.2024.100098","journal-title":"Microbe"},{"issue":"1","key":"5271_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/cells12010075","volume":"12","author":"C Lu","year":"2022","unstructured":"Lu C, Ren S, Xie W, Zhao Z, Wu X, Guo S, Suo A, Zhou N, Yang J, Wu S, Zheng Y (2022) Characterizing relevant MicroRNA editing sites in Parkinson\u2019s disease. Cells 12(1):75. https:\/\/doi.org\/10.3390\/cells12010075","journal-title":"Cells"},{"key":"5271_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04128-1","author":"SK Hamidpour","year":"2024","unstructured":"Hamidpour SK, Amiri M, Ketabforoush AHME, Saeedi S, Angaji A, Tavakol S (2024) Unraveling dysregulated cell signaling pathways, genetic and epigenetic mysteries of Parkinson\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04128-1","journal-title":"Mol Neurobiol"},{"issue":"4","key":"5271_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1055\/s-0043-1771461","volume":"43","author":"L Talman","year":"2023","unstructured":"Talman L, Safarpour D (2023) An overview of gastrointestinal dysfunction in Parkinsonian syndromes. Semin Neurol 43(4):583\u2013597. https:\/\/doi.org\/10.1055\/s-0043-1771461","journal-title":"Semin Neurol"},{"issue":"2","key":"5271_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12264-023-01115-9","volume":"40","author":"C Hu","year":"2024","unstructured":"Hu C, Yan Y, Jin Y, Yang J, Xi Y, Zhong Z (2024) Decoding the cellular trafficking of prion-like proteins in neurodegenerative diseases. Neurosci Bull 40(2):241\u2013254. https:\/\/doi.org\/10.1007\/s12264-023-01115-9","journal-title":"Neurosci Bull"},{"issue":"7","key":"5271_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11910-022-01196-5","volume":"22","author":"RA Manfready","year":"2022","unstructured":"Manfready RA, Forsyth CB, Voigt RM, Hall DA, Goetz CG, Keshavarzian A (2022) Gut-brain communication in Parkinson\u2019s disease: enteroendocrine regulation by GLP-1. Curr Neurol Neurosci Rep 22(7):335\u2013342. https:\/\/doi.org\/10.1007\/s11910-022-01196-5","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"5271_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/ijms25010038","volume":"25","author":"LMT Dicks","year":"2023","unstructured":"Dicks LMT (2023) Our mental health is determined by an intrinsic interplay between the central nervous system, enteric nerves, and gut microbiota. Int J Mol Sci 25(1):38. https:\/\/doi.org\/10.3390\/ijms25010038","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5271_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/acs.chemrev.2c00431","volume":"123","author":"N Aggarwal","year":"2023","unstructured":"Aggarwal N, Kitano S, Puah GRY, Kittelmann S, Hwang IY, Chang MW (2023) Microbiome and human health: current understanding, engineering, and enabling technologies. Chem Rev 123(1):31\u201372. https:\/\/doi.org\/10.1021\/acs.chemrev.2c00431","journal-title":"Chem Rev"},{"issue":"2","key":"5271_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mds.26480","volume":"31","author":"C Ruffmann","year":"2016","unstructured":"Ruffmann C, Parkkinen L (2016) Gut feelings about alpha-synuclein in gastrointestinal biopsies: biomarker in the making? Mov Disord 31(2):193\u2013202. https:\/\/doi.org\/10.1002\/mds.26480","journal-title":"Mov Disord"},{"issue":"6","key":"5271_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"K Shannon","year":"2012","unstructured":"Shannon K, Keshavarzian MA, Dodiya HB, Jakate S, Kordower JH (2012) Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? evidence from 3 cases. Mov Disord 27(6):716\u2013719. https:\/\/doi.org\/10.1002\/mds.25020","journal-title":"Mov Disord"},{"key":"5271_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainresbull.2022.02.015","volume":"183","author":"S Dong","year":"2022","unstructured":"Dong S, Sun M, He C, Cheng H (2022) Brain-gut-microbiota axis in Parkinson\u2019s disease: a historical review and future perspective. Brain Res Bull 183:84\u201393. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.02.015","journal-title":"Brain Res Bull"},{"key":"5271_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.757515","volume":"14","author":"PP Guan","year":"2021","unstructured":"Guan PP, Cao LL, Yang Y, Wang P (2021) Calcium ions aggravate Alzheimer\u2019s disease through the aberrant activation of neuronal networks, leading to synaptic and cognitive deficits. Front Mol Neurosci 14:757515. https:\/\/doi.org\/10.3389\/fnmol.2021.757515","journal-title":"Front Mol Neurosci"},{"key":"5271_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90:675\u2013691. https:\/\/doi.org\/10.1016\/j.neuron.2016.03.038","journal-title":"Neuron"},{"key":"5271_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.spen.2017.12.005","volume":"25","author":"A Fazl","year":"2018","unstructured":"Fazl A, Fleisher J (2018) Anatomy, physiology, and clinical syndromes of the basal ganglia: a brief review. Semin Pediatr Neurol 25:2\u20139. https:\/\/doi.org\/10.1016\/j.spen.2017.12.005","journal-title":"Semin Pediatr Neurol"},{"issue":"9","key":"5271_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","volume":"85","author":"Y Su","year":"2019","unstructured":"Su Y, Deng MF, Xiong W, Xie AJ, Guo J, Liang ZH, Hu B, Chen JG, Zhu X, Man HY, Lu Y, Liu D, Tang B, Zhu LQ (2019) MicroRNA-26a\/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson\u2019s disease. Biol Psychiatry 85(9):769\u2013781. https:\/\/doi.org\/10.1016\/j.biopsych.2018.12.008","journal-title":"Biol Psychiatry"},{"issue":"2","key":"5271_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/155005941004100204","volume":"41","author":"M DeLong","year":"2010","unstructured":"DeLong M, Wichmann T (2010) Changing views of basal ganglia circuits and circuit disorders. Clin EEG Neurosci 41(2):61\u201367. https:\/\/doi.org\/10.1177\/155005941004100204","journal-title":"Clin EEG Neurosci"},{"key":"5271_CR27","doi-asserted-by":"publisher","first-page":"41432","DOI":"10.1038\/srep41432","volume":"7","author":"D Gagnon","year":"2017","unstructured":"Gagnon D, Petryszyn S, Sanchez MG, Bories C, Beaulieu JM, De Koninck Y, Parent A, Parent M (2017) Striatal neurons expressing D1 and D2 receptors are morphologically distinct and differently affected by dopamine denervation in mice. Sci Rep 7:41432. https:\/\/doi.org\/10.1038\/srep41432","journal-title":"Sci Rep"},{"issue":"6","key":"5271_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of parkinson disease: a review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"issue":"7","key":"5271_CR29","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1212\/WNL.0000000000004953","volume":"90","author":"PC Lee","year":"2018","unstructured":"Lee PC, Ahmed I, Loriot MA, Mulot C, Paul KC, Bronstein JM, Ritz B, Elbaz A (2018) Smoking and Parkinson disease: evidence for gene-by-smoking interactions. Neurology 90(7):e583\u2013e592. https:\/\/doi.org\/10.1212\/WNL.0000000000004953","journal-title":"Neurology"},{"issue":"1","key":"5271_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/WNL.0000000000004057","volume":"89","author":"KC Hughes","year":"2017","unstructured":"Hughes KC, Gao X, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A (2017) Intake of dairy foods and risk of Parkinson disease. Neurology 89(1):46\u201352. https:\/\/doi.org\/10.1212\/WNL.0000000000004057","journal-title":"Neurology"},{"issue":"4","key":"5271_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.28902","volume":"37","author":"C Domenighetti","year":"2023","unstructured":"Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A, Schulte C, Grover S, Mohamed O, Portugal B, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschl\u00e4nder AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Kawamura Y, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstr\u00f8m L, Correia Guedes L, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Hellberg C, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Kr\u00fcger R, Gasser T, Sharma M, Elbaz A (2023) Comprehensive unbiased risk factor assessment for genetics and environment in Parkinson\u2019s Disease (Courage-PD) consortium dairy intake and Parkinson\u2019s disease: A Mendelian Randomization Study. Mov Disord 37(4):857\u2013864. https:\/\/doi.org\/10.1002\/mds.28902","journal-title":"Mov Disord"},{"key":"5271_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jneuroim.2019.01.004","volume":"328","author":"SR Sarkar","year":"2019","unstructured":"Sarkar SR, Banerjee S (2019) Gut microbiota in neurodegenerative disorders. J Neuroimmunol 328:98\u2013104. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.01.004","journal-title":"J Neuroimmunol"},{"key":"5271_CR33","doi-asserted-by":"publisher","first-page":"5127157","DOI":"10.1155\/2023\/5127157","volume":"2023","author":"Y Zang","year":"2023","unstructured":"Zang Y, Lai X, Li C, Ding D, Wang Y, Zhu Y (2023) The role of gut microbiota in various neurological and psychiatric disorders-an evidence mapping based on quantified evidence. Mediators Inflamm 2023:5127157. https:\/\/doi.org\/10.1155\/2023\/5127157","journal-title":"Mediators Inflamm"},{"key":"5271_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2022.102652","volume":"78","author":"A Ratsika","year":"2023","unstructured":"Ratsika A, Cruz Pereira JS, Lynch CMK, Clarke G, Cryan JF (2023) Microbiota-immune-brain interactions: a lifespan perspective. Curr Opin Neurobiol 78:102652. https:\/\/doi.org\/10.1016\/j.conb.2022.102652","journal-title":"Curr Opin Neurobiol"},{"issue":"9","key":"5271_CR35","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.cell.2021.03.024","volume":"184","author":"L Chen","year":"2021","unstructured":"Chen L, Wang D, Garmaeva S, Kurilshikov A, Vich Vila A, Gacesa R, Sinha T, Weersma RK, Wijmenga C, Zhernakova A, Fu J, Lifelines Cohort Study (2021) The long-term genetic stability and individual specificity of the human gut microbiome. Cell 184(9):2302\u20132315. https:\/\/doi.org\/10.1016\/j.cell.2021.03.024","journal-title":"Cell"},{"issue":"12","key":"5271_CR36","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.3390\/nu6125786","volume":"6","author":"S Schippa","year":"2014","unstructured":"Schippa S, Conte MP (2014) Dysbiotic events in gut microbiota: impact on human health. Nutrients 6(12):5786\u20135805. https:\/\/doi.org\/10.3390\/nu6125786","journal-title":"Nutrients"},{"issue":"4","key":"5271_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4161\/gmic.29810","volume":"5","author":"ML Jones","year":"2014","unstructured":"Jones ML, Ganopolsky JG, Martoni CJ, Labb\u00e9 A, Prakash S (2014) Emerging science of the human microbiome. Gut Microbes 5(4):446\u2013457. https:\/\/doi.org\/10.4161\/gmic.29810","journal-title":"Gut Microbes"},{"issue":"2","key":"5271_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1113\/JP273106","volume":"595","author":"TG Dinan","year":"2017","unstructured":"Dinan TG, Cryan JF (2017) Gut instincts: The microbiota as a key regulator of brain development, aging, and neurodegeneration. J Physiol 595(2):489\u2013503. https:\/\/doi.org\/10.1113\/JP273106","journal-title":"J Physiol"},{"issue":"11","key":"5271_CR39","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474(11):1823\u20131836. https:\/\/doi.org\/10.1042\/BCJ20160510","journal-title":"Biochem J"},{"key":"5271_CR40","doi-asserted-by":"publisher","first-page":"1348279","DOI":"10.3389\/fcimb.2024.1348279","volume":"14","author":"NU Mahbub","year":"2024","unstructured":"Mahbub NU, Islam MM, Hong ST, Chung HJ (2024) Dysbiosis of the gut microbiota and its effect on alpha-synuclein and prion protein misfolding: consequences for neurodegeneration. Front Cell Infect Microbiol 14:1348279. https:\/\/doi.org\/10.3389\/fcimb.2024.1348279","journal-title":"Front Cell Infect Microbiol"},{"issue":"263","key":"5271_CR41","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, T\u00f3th M, Korecka A, Bakocevic N, Ng LG, Kundu P, Guly\u00e1s B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6(263):263ra158. https:\/\/doi.org\/10.1126\/scitranslmed.3009759","journal-title":"Sci Transl Med"},{"issue":"6","key":"5271_CR42","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK (2016) Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469\u201380.e12. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","journal-title":"Cell"},{"issue":"6","key":"5271_CR43","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/nu10060708","volume":"10","author":"S Gerhardt","year":"2018","unstructured":"Gerhardt S, Mohajeri M (2018) Changes of colonic bacterial composition in Parkinson\u2019s disease and other neurodegenerative diseases. Nutrients 10(6):708. https:\/\/doi.org\/10.3390\/nu10060708","journal-title":"Nutrients"},{"issue":"1","key":"5271_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, W\u00fcllner U (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9(1):39. https:\/\/doi.org\/10.1186\/s13073-017-0428-y","journal-title":"Genome Med"},{"key":"5271_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuro.2018.02.013","volume":"65","author":"ME Johnson","year":"2018","unstructured":"Johnson ME, Stringer A, Bobrovskaya L (2018) Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson\u2019s disease. Neurotoxicology 65:174\u2013185. https:\/\/doi.org\/10.1016\/j.neuro.2018.02.013","journal-title":"Neurotoxicology"},{"key":"5271_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.12.012","volume":"135","author":"HB Dodiya","year":"2020","unstructured":"Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, Pahan K, Shannon KM, Keshavarzian A (2020) Chronic stress-induced gut dysfunction exacerbates Parkinson\u2019s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson\u2019s disease. Neurobiol Dis 135:104352. https:\/\/doi.org\/10.1016\/j.nbd.2018.12.012","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5271_CR47","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41598-018-19646-x","volume":"8","author":"JG Choi","year":"2018","unstructured":"Choi JG, Kim N, Ju IG, Eo H, Lim SM, Jang SE, Kim DH, Oh MS (2018) Oral administration of proteus mirabilis damages dopaminergic neurons and motor functions in mice. Sci Rep 8(1):1275. https:\/\/doi.org\/10.1038\/s41598-018-19646-x","journal-title":"Sci Rep"},{"key":"5271_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, Hamidi GA, Salami M (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s Disease: a randomized, double-blind and controlled trial. Front Aging Neurosci 8:256. https:\/\/doi.org\/10.3389\/fnagi.2016.00256","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"5271_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142164","volume":"10","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K, Shibata A, Fujisawa Y, Minato T, Okamoto A, Ohno K, Hirayama M (2015) Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease. PLoS ONE 10(11):e0142164. https:\/\/doi.org\/10.1371\/journal.pone.0142164","journal-title":"PLoS ONE"},{"key":"5271_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, Fa\u00dfbender K, Schwiertz A, Sch\u00e4fer KH (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.08.019","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"5271_CR51","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome: PD, medications, and gut microbiome. Mov Disord 32(5):739\u2013749. https:\/\/doi.org\/10.1002\/mds.26942","journal-title":"Mov Disord"},{"issue":"6","key":"5271_CR52","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov VA, Saltykova IV, Zhukova IA, Alifirova VM, Zhukova NG, Dorofeeva YB, Tyakht AV, Kovarsky BA, Alekseev DG, Kostryukova ES, Mironova YS, Izhboldina OP, Nikitina MA, Perevozchikova TV, Fait EA, Babenko VV, Vakhitova MT, Govorun VM, Sazonov AE (2017) Analysis of gut microbiota in patients with Parkinson\u2019s disease. Bull Exp Biol Med 162(6):734\u2013737. https:\/\/doi.org\/10.1007\/s10517-017-3700-7","journal-title":"Bull Exp Biol Med"},{"key":"5271_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105187","volume":"160","author":"Z Yan","year":"2021","unstructured":"Yan Z, Yang F, Cao J, Ding W, Yan S, Shi W, Wen S, Yao L (2021) Alterations of gut microbiota and metabolome with Parkinson\u2019s disease. Microb Pathog 160:105187. https:\/\/doi.org\/10.1016\/j.micpath.2021.105187","journal-title":"Microb Pathog"},{"key":"5271_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Lu M, Du RH, Qiao C, Jiang CY, Zhang KZ, Ding JH, Hu G (2016) MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener 11:28. https:\/\/doi.org\/10.1186\/s13024-016-0094-3","journal-title":"Mol Neurodegener"},{"issue":"2","key":"5271_CR55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","volume":"31","author":"D Li","year":"2018","unstructured":"Li D, Yang H, Ma J, Luo S, Chen S, Gu Q (2018) MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3. Hum Cell 31(2):106\u2013115. https:\/\/doi.org\/10.1007\/s13577-017-0187-5","journal-title":"Hum Cell"},{"issue":"11","key":"5271_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0020362","volume":"2","author":"S Shendelman","year":"2004","unstructured":"Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2(11):e362. https:\/\/doi.org\/10.1371\/journal.pbio.0020362","journal-title":"PLoS Biol"},{"key":"5271_CR57","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","volume":"9","author":"Y Chen","year":"2017","unstructured":"Chen Y, Gao C, Sun Q, Pan H, Huang P, Ding J, Chen S (2017) MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson\u2019s disease. Front Aging Neurosci 9:232. https:\/\/doi.org\/10.3389\/fnagi.2017.00232","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"5271_CR58","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1515\/cclm-2012-0360","volume":"50","author":"Y Sun","year":"2012","unstructured":"Sun Y, Zhang K, Fan G, Li J (2012) Identification of circulating microRNAs as biomarkers in cancers: what have we got? Clin Chem Lab Med 50(12):2121\u20132126. https:\/\/doi.org\/10.1515\/cclm-2012-0360","journal-title":"Clin Chem Lab Med"},{"issue":"Pt A","key":"5271_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbr.2017.01.021","volume":"322","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, Zeng BH, Li WW, Zhou CJ, Fan SH, Cheng K, Zeng L, Zheng P, Fang L, Wei H, Xie P (2017) Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice. Behav Brain Res 322(Pt A):34\u201341. https:\/\/doi.org\/10.1016\/j.bbr.2017.01.021","journal-title":"Behav Brain Res"},{"issue":"3","key":"5271_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/1573406411666151030112140","volume":"12","author":"G Mushtaq","year":"2016","unstructured":"Mushtaq G, Greig NH, Anwar F, Zamzami MA, Choudhry H, Shaik MM, Tamargo IA, Kamal MA (2016) miRNAs as circulating biomarkers for Alzheimer\u2019s disease and Parkinson\u2019s disease. Med Chem 12(3):217\u2013225. https:\/\/doi.org\/10.2174\/1573406411666151030112140","journal-title":"Med Chem"},{"issue":"1","key":"5271_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13041-019-0471-2","volume":"12","author":"H Uwatoko","year":"2019","unstructured":"Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H (2019) Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson\u2019s disease. Mol Brain 12(1):49. https:\/\/doi.org\/10.1186\/s13041-019-0471-2","journal-title":"Mol Brain"},{"issue":"3","key":"5271_CR62","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/mds.27935","volume":"35","author":"M Cressatti","year":"2020","unstructured":"Cressatti M, Juwara L, Galindez JM, Velly AM, Nkurunziza ES, Marier S, Canie O, Gornistky M, Schipper HM (2020) Salivary microR-153 and microR-223 levels as potential diagnostic biomarkers of idiopathic Parkinson\u2019s disease. Mov Disord 35(3):468\u2013477. https:\/\/doi.org\/10.1002\/mds.27935","journal-title":"Mov Disord"},{"issue":"1","key":"5271_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40168-017-0321-3","volume":"5","author":"AE Hoban","year":"2017","unstructured":"Hoban AE, Stilling RM, Moloney GM, Moloney RD, Shanahan F, Dinan TG, Cryan JF, Clarke G (2017) Microbial regulation of microRNA expression in the amygdala and prefrontal cortex. Microbiome 5(1):102. https:\/\/doi.org\/10.1186\/s40168-017-0321-3","journal-title":"Microbiome"},{"issue":"7","key":"5271_CR64","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.3390\/ijms24076794","volume":"24","author":"YZ Lee","year":"2023","unstructured":"Lee YZ, Cheng SH, Chang MY, Lin YF, Wu CC, Tsai YC (2023) Neuroprotective effects of lactobacillus plantarum PS128 in a mouse model of Parkinson\u2019s disease: the role of gut microbiota and MicroRNAs. Int J Mol Sci 24(7):6794. https:\/\/doi.org\/10.3390\/ijms24076794","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5271_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.756","volume":"7","author":"G Ceccarelli","year":"2017","unstructured":"Ceccarelli G, Fratino M, Selvaggi C, Giustini N, Serafino S, Schietroma I, Corano Scheri G, Pavone P, Passavanti G, Alunni Fegatelli D, Mezzaroma I, Antonelli G, Vullo V, Scagnolari C, d\u2019Ettorre G (2017) A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients. Brain Behav 7(8):e00756. https:\/\/doi.org\/10.1002\/brb3.756","journal-title":"Brain Behav"},{"issue":"4","key":"5271_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2055-6640(20)30322-8","volume":"3","author":"G Frattari","year":"2017","unstructured":"Frattari G, Aagaard L, Denton PW (2017) The role of miR-29a in HIV-1 replication and latency. J Virus Erad 3(4):185\u2013191","journal-title":"J Virus Erad"},{"key":"5271_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fnins.2019.00113","volume":"13","author":"C Hewel","year":"2019","unstructured":"Hewel C, Kaiser J, Wierczeiko A, Linke J, Reinhardt C, Endres K, Gerber S (2019) Common miRNA patterns of Alzheimer\u2019s disease and Parkinson\u2019s disease and their putative impact on commensal gut microbiota. Front Neurosci 13:113. https:\/\/doi.org\/10.3389\/fnins.2019.00113","journal-title":"Front Neurosci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05271-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:45:15Z","timestamp":1757148315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05271-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["5271"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05271-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}